2BBBullish & Bearish
Health Care

Ocular Therapeutix, Inc. (OCUL) Stock Score & Signals

Ocular Therapeutix, Inc. (OCUL) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 24 out of 100.

2BB score and signals

Ocular Therapeutix, Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.

SignalScoreReading
Activity12Very Low
Momentum50Stable
Financial strength30Weak
Quality100Very Strong
Risk44Moderate

Company facts

CEOPravin Dugel
HeadquartersBedford, Massachusetts, United States
Founded2006
Employees325
52-week range$6.23 – $16.44

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-02-03—-0.3924—$14.34M
2026-11-02—-0.3692—$14.49M
2026-08-10—-0.4034—$13.46M
2026-05-04—-0.3242—$12.68M